Table 3

Inpatient and final histologic results

Hospitalization time [Mean±SD (Range)]; day3.7±1.1 (2–6)
Complications (Clavien–Dindo); n(%)
 Grade I0 (0)
 Grade II1 (5)
 Grade III1 (5)
 Grade IV0 (0)
 Grade V0 (0)
Adverse events related with 99m TC or ICG use (<30 days); n (%)0 (0)
Histotype; n (%)
 Serous4 (20)
 Endometrioid8 (40)
 Mucinous2 (10)
 Clear cells5 (25)
 Other1 (5)
Grade; n (%)
 G18 (40)
 G20 (0)
 G311 (55)
 Not applicable (disgerminoma)1 (5)
ILV; n (%)0 (0)
FIGO stage; n (%)
 IA7 (35)
 IC11 (55)
 IIA1 (5)
 IIIB1 (5)
Pelvic LND [Mean±SD (Range)]; nodes20.1±7.6 (9–74)
Para-aortic LND [Mean±SD (Range)]; nodes19.8±10.4 (6–40)
Pelvic SLN removed [Mean±SD (Range)]; nodes2.2±1.5 (0–5)
Para-aortic SLN removed [Mean±SD (Range)]; nodes3.3±1.8 (1–7)
  • FIGO, The International Federation of Gynecology and Obstetrics; ICG, Indocyanine green; LND, lymphadenectomy; LVI, lymph vascular invasion; SLN, sentinel lymph node.